FDA Set to Review Peptide Access for Compounding Pharmacies | Drug Topics
Author(s)Brian The FDA’s Pharmacy Compounding Advisory Committee will meet in late July of 2026 to convene on peptides and their inclusion on the 503A Bulk Drug Substances List. Following recent comments from the US Department of Health and Human…